Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJena University Hospital

About this trial

The aim of the study is to clarify whether the perioperative release of the cardiac biomarkers troponin I, troponin T and CK-MB consistently correlate with visualizable myocardial damage, and to what extent these biomarkers are comparable by means of their kinetics and dynamics.

Due to the uncertainty regarding the validity of cardiac biomarkers in the diagnosis of myocardial infarction, the answer to these questions could have a considerable influence on internationally valid guidelines and definitions. International studies, especially in the field of coronary surgery and coronary artery disease treatment refer to these definitions, in particular, the adequate treatment of affected patients is directly dependent on them.

Eligibility criteria

Qualifiers

Indication for isolated aortic or mitral valve surgery

Written informed consent

Age ≥ 18 years

Disqualifiers

Presence of coronary artery disease (excluded within the last 6 months)

Allergy to gadolinium

Cochlear implant

Deep brain stimulation

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators